A common osteoporosis drug blocked spinal damage in a surprising new study
Researchers have discovered a link between genetics and spinal degeneration, and found an osteoporosis drug to be effective in preventing mineral buildup in zebrafish spines. The study's findings could lead to new treatments for chronic back pain. A common medication has been shown to stop damage from occurring.
Why it's good news: It offers a potential solution to alleviate the suffering of millions of people worldwide who experience chronic back pain.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →More Health stories
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →